Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acids are long-chain carboxylic acids and fundamental building blocks of lipids such as triglycerides, phospholipids, and sterol esters[3][5][9]. They are usually unbranched, contain an even number of carbon atoms (typically 12–22), and can be saturated (no double bonds) or unsaturated (one or more double bonds)[3][5][7]. In biological systems, fatty acids play key roles in energy storage, cellular membrane structure, signaling, and regulation of gene expression[4][6][8]. They are not a single molecule or receptor but a class of molecules. They are transformed in the body through processes such as β-oxidation (for ATP production), esterification (for storage), and serve as precursors for signaling lipids like eicosanoids[4][8]. Fatty acids influence many physiological states and disease risk but are not themselves considered a drug target; instead, enzymes, receptors, and transporters that bind, synthesize, or metabolize fatty acids (such as fatty acid synthase, PPARs, and fatty acid-binding proteins) are typical drug targets[2][6]. Fatty acids are classified as "Other" in molecular target frameworks and should not be listed as a therapeutic target or receptor[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acids.